Autres langues Healios K.K.

Actions

4593

JP3835100003

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
147 ^JPY	-0,68 %		+1,38 %	-10,91 %

09/04	Healios K.K. conclut un accord de recherche conjointe avec AND Medical Group	CI
03/04	Healios K.K. (TSE:4593) a conclu l'acquisition de la quasi-totalité des actifs d'Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc (OTCPK:ATHX.Q), ReGenesys BVBA et ReGenesys, LLC.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen	10/04
Healios K.K. Enters into Joint Research Agreement with AND Medical Group	09/04
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data	26/02
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation	26/02
Healios K.K. announced that it has received ¥2.2600715 billion in funding	09/02
Healios K.K. and ProcellCure Inc. Announce Start of ARDS Clinical Trial in Japan	02/02
Healios K.K. announced that it expects to receive ¥2.2600715 billion in funding	25/01
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment	18/01
Japanese Shares Finish Lower After Key Economic Data	18/01
Healios K.K. and Its Wholly Owned Subsidiary ProcellCure Inc. Announce Submission of ARDS Clinical Trial Notification in Japan	18/01
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01
Healios Secures LOI on Joint Research with AND	17/01
Healios K.K. AND Medical Group Enter into A Letter of Intent for A Basic Agreement for Joint Research	16/01
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	05/01
Healios, Nobelpharma in Talks for Stem Cell Therapy Alliance for ARDS	28/12
Healios Invests in Arktus Therapeutics at Undisclosed Amount	26/12
Healios K.K. (TSE : 4593) agreed to acquire an unknown minority stake in Arktus Therapeutics Co., Ltd.	22/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Healios K.K.

Actions

4593

JP3835100003

Autres langues

Filtres